Cambridge, UK: 27^th April 2021

One Nucleus, the not-for-profit Life Science membership group headquartered in Cambridge, has welcomed EY to its Partner Programme.

The group supports growing Life Science businesses through their life cycle, as they translate great science into better patient outcomes. This includes facilitating connections between compliance, tax, investment and international growth.

Tony Jones, CEO of One Nucleus commented: ‘We are delighted to welcome EY to the One Nucleus Partner Programme. We look forward to connecting our members with their expertise and platforms such as their 7 Drivers of Growth framework.

“One Nucleus is entirely focused on bringing great innovation, leadership and investment together to enable translation of world class science to patient benefit and strong returns for all stakeholders. EY brings immense expertise, connectivity and capacity both globally and in the UK to help us in that endeavour.”

Stuart Wilkinson, Office Managing Partner at EY in Cambridge added: “EY has a depth of knowledge and wealth of experience supporting high growth companies in the Life Sciences industry across the global and the UK, including in our Cambridge Life Sciences Hub and working across the Oxford-Cambridge Arc.  We’re pleased to be joining the One Nucleus Partner Programme, which alongside its Virtual Innovation Centre platform, brings opportunities for EY to engage and connect with more local businesses, who are at the forefront of healthcare and biotechnology innovation. We look forward to working with the team in the future.”